Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 4:5:1207612.
doi: 10.3389/ftox.2023.1207612. eCollection 2023.

Exposure to Dichlorvos pesticide alters the morphology of and lipid metabolism in the ventral prostate of rats

Affiliations

Exposure to Dichlorvos pesticide alters the morphology of and lipid metabolism in the ventral prostate of rats

Giovanna Galo Quintino-Ottonicar et al. Front Toxicol. .

Abstract

Organophosphate pesticides are widely used in agriculture, leading to soil, water, and food contamination. Among these compounds is Dichlorvos [O,O-dimethyl O-(2,2-dichlorovinyl)phosphate, DDVP], which is listed as a highly toxic compound by the Environmental Protection Agency and World Health Organization. Exposure to DDVP can result in nervous, respiratory, hepatic, and reproductive abnormalities, in addition to endocrine disrupting, mutagenic, and carcinogenic effects. Little is known about the impacts of DDVP on the reprogramming of lipid metabolism, which is also associated with the development and progression of cancer, since the tumor cells need to recruit, capture, and use fatty acids to compose their building membranes. This study aimed to evaluate the influence of the pesticide DDVP on lipid metabolism in the prostate, after chemical induction by the carcinogen N-methyl-N-nitrosourea (MNU). For this, 32 Fischer rats aged 90 days were randomly divided into four experimental groups: Control, DDVP, MNU, and MNU + DDVP. The MNU and MNU + DDVP groups underwent chemical induction with MNU (15 mg/kg) and the DDVP and MNU + DDVP groups received a diet supplemented with DDVP (10 mg/kg). Histopathological analyses of the rat ventral prostate showed 100% incidence of epithelial hyperplasia in the MNU and MNU + DDVP groups. This finding was accompanied by an increase of the epithelial compartment in the MNU + DDVP group. Immunolocalization of important proteins linked to lipid metabolism has been established. In the MNU + DDVP group, Western blotting analyses pointed out an increased expression of the protein LIMP II (Lysosomal Integral Membrane Protein-II), which is correlated with the capture and distribution of lipids in tumor cells. Together, these results indicate that the association of a low dose of DDVP with MNU was able to promote alterations in the morphology and lipid metabolism of the rat ventral prostate, which may be related to tumor progression in this organ.

Keywords: CD36; Dichlorvos; LIMP-II; SCAP; SREBP; lipid metabolism; prostate cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Diagram of experimental groups.
FIGURE 2
FIGURE 2
Panoramic view of ventral prostate stained by hematoxylin-eosin regarding the experimental groups: Control Group (A, B), DDVP Group (C), MNU Group (D), and MNU + DDVP group (E). Lu = lumen, Ep = epithelium, St = stroma.
FIGURE 3
FIGURE 3
Morphological characterization of ventral prostate lesions stained by hematoxylin-eosin. (A) Area of epithelial atrophy observed in the DDVP group, in contrast to regions of normal epithelium. (B) Epithelium presenting cellular atypia, characterized by the presence of cytoplasmic inclusions. Findings of the MNU group. (C) Highlighted area of cellular atypia also observed in the MNU + DDVP group. (D) Presence of periacinary inflammatory focus in the DDVP group. (E, F) Area of epithelial metaplasia in the MNU + DDVP group. (G–I) Regions of epithelial hyperplasia in the MNU + DDDVP group. Lu = lumen, Ep = epithelium, St = stroma, arrow = presence of cytoplasmic inclusions, At = epithelial atypia, Inf = periacinary inflammation, Met = epithelial metaplasia, Hyp = epithelial hyperplasia.
FIGURE 4
FIGURE 4
Representative histological sections of the ventral prostate immunostaining to the target proteins. SCAP showed dispersed coloring in the cytoplasm and some markings in the apical region. CD36 was marked predominantly in the region of the Golgi complex. LIMP II was marked as clusters in the cytoplasm and the apical membrane. SREBP was marked predominantly in the region of the Golgi complex, but there were also scattered markings in the cytoplasm. The arrows point to positive marks. Lu = lumen, Ep = epithelium, St = stroma.
FIGURE 5
FIGURE 5
SCAP, CD36, LIMP-II, and SREBP expression levels in the prostate, by Western blotting (n = 8). The target bands were quantified and normalized by β-actin expression (left). Each bar represents the mean ± SD of the experimental groups. Statistical analysis was performed using ANOVA followed by Tukey. *** p ≤ 0.001 (right).

Similar articles

Cited by

References

    1. Bedia C., Dalmau N., Jaumot J., Tauler R. (2015). Phenotypic malignant changes and untargeted lipidomic analysis of long-term exposed prostate cancer cells to endocrine disruptors. Environ. Res. 140, 18–31. 10.1016/j.envres.2015.03.014 - DOI - PubMed
    1. Bosland M. C., Prinsen M. K., Dirksen T. J., Spit B. J. (1990). Characterization of adenocarcinomas of the dorsolateral prostate induced in Wistar rats by N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl, following sequential treatment with cyproterone acetate and testosterone propionate. Cancer Res. 50, 700–709. - PubMed
    1. Brown M. S., Goldstein J. L. (2009). Cholesterol feedback: From schoenheimer's bottle to scap's MELADL. J. Lipid. Res. 50, 15–27. 10.1194/jlr.R800054-JLR200 - DOI - PMC - PubMed
    1. Calle E. E., Rodriguez C. M. D., Walker-Thurmond K., Thun M. J. (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults. N. Engl. J. Med. 348 (17), 1625–1638. 10.1056/NEJMoa021423 - DOI - PubMed
    1. Corti M., Lorenzetti S., Ubaldi A., Zilli R., Marcoccia D. (2022). Endocrine disruptors and prostate cancer. Int. J. Mol. Sci. 23 (3), 1216. 10.3390/ijms23031216 - DOI - PMC - PubMed

LinkOut - more resources